Package 65862-687-05

{"route": ["ORAL"], "spl_id": "dca8eddf-c54f-4b6e-b56c-19d6dd3e7e90", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "upc": ["0365862687302"], "unii": ["O3J8G9O825"], "rxcui": ["900575"], "spl_set_id": ["11f757f1-cf48-47a8-925e-918359cbd2d4"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (65862-687-01)", "package_ndc": "65862-687-01", "marketing_start_date": "20180917"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-687-05)", "package_ndc": "65862-687-05", "marketing_start_date": "20180917"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-687-30)", "package_ndc": "65862-687-30", "marketing_start_date": "20180917"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (65862-687-99)", "package_ndc": "65862-687-99", "marketing_start_date": "20180917"}], "brand_name": "Ritonavir", "product_id": "65862-687_dca8eddf-c54f-4b6e-b56c-19d6dd3e7e90", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "65862-687", "generic_name": "Ritonavir", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritonavir", "active_ingredients": [{"name": "RITONAVIR", "strength": "100 mg/1"}], "application_number": "ANDA206614", "marketing_category": "ANDA", "marketing_start_date": "20180917", "listing_expiration_date": "20261231"}